SEVERE EOSINOPHILIC ASTHMA
Clinical trials for SEVERE EOSINOPHILIC ASTHMA explained in plain language.
Never miss a new study
Get alerted when new SEVERE EOSINOPHILIC ASTHMA trials appear
Sign up with your email to follow new studies for SEVERE EOSINOPHILIC ASTHMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
BREATHING EASIER: asthma drug may let patients ditch some daily pills
Disease control OngoingThis study tests whether the drug benralizumab can help people with severe eosinophilic asthma safely reduce their daily controller medications. About 504 Chinese patients aged 12 to 75 will try to step down their usual asthma treatments while staying on benralizumab. The goal is…
Matched conditions: SEVERE EOSINOPHILIC ASTHMA
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 17, 2026 05:29 UTC
-
New study explores Mepolizumab's impact on nasal polyps and asthma
Knowledge-focused OngoingThis observational study follows 40 patients with chronic sinusitis and nasal polyps, with or without severe asthma, who are taking mepolizumab. Researchers will collect nasal, blood, and sputum samples over 12 months to track changes in symptoms, airway bacteria, and gene activi…
Matched conditions: SEVERE EOSINOPHILIC ASTHMA
Sponsor: National and Kapodistrian University of Athens • Aim: Knowledge-focused
Last updated May 15, 2026 12:07 UTC